EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Redefining Anthracycline-Related Subclinical Cardiotoxicity: ‘Absolute’ and ‘Relative’ Change in Longitudinal Strain

Andrew Terluk iD, Luke Stefani, Anita Boyd, Kim Vo, Karen Byth, Rina Hui, David Richards, Liza Thomas

ESC Heart Failure · 2024

DOI: 10.1002/ehf2.14884 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ESC Heart Failure, 2024. Verfasst von Andrew Terluk und 7 weiteren Autor:innen. Beteiligte Einrichtung: Westmead Clinical School, The University of Sydney, Camperdown, Australia. Hauptthemen laut MEDLINE: Anthracyclines, Cardiotoxicity, Echocardiography, Breast Neoplasms. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Anthracycline chemotherapy (AC) for breast cancer can cause cancer therapy-related cardiac dysfunction (CTRCD) with resultant heart failure, traditionally defined as a reduction in left ventricular (LV) ejection fraction on echocardiography. In recent years, global longitudinal systolic strain (GLS) has been used to identify subclinical cardiac dysfunction prior to development of overt CTRCD. Recent harmonized guidelines have incorporated GLS into definitions for CTRCD to identify cardiac dysfunction and inform decisions regarding cardioprotective strategies. Methods and results We evaluated subclinical dysfunction in breast cancer patients treated with AC and determined the echocardiographic and patient factors associated with significant GLS changes. One hundred fourteen HER2 negative patients treated with AC were prospectively recruited and underwent serial echocardiograms (LVEF and LVGLS) at three time points (prior to AC, 3 months, and 1 year). CTRCD was defined as an asymptomatic reduction in LVEF of 10% or symptomatic drop of 5% to LVEF <53%. Subclinical LV dysfunction was defined as a reduction of ≥10% in GLS compared with baseline, recognizing that this cut off identified an ‘at risk cohort’ rather than patients with established CTRCD. No participant demonstrated CTRCD by reduction in LVEF. Forty-three patients (38%) demonstrated a ≥10% relative reduction in GLS at 12 months; 20/43 (47%) had a reduced absolute GLS to <16%, and were older, had hypertension, increased LV mass, lower baseline e′ velocity and GLS. GLS ≥20.5% at baseline yielded a sensitivity of 79% and specificity of 87% for a normal GLS (i.e., ≥16%) at 1 year despite a ≥10% reduction from baseline.

Conclusions

We present a stepwise evaluation for subclinical LV dysfunction using both a relative reduction in GLS combined with an absolute reduction in GLS. We believe our findings may re-stratify patients with a high baseline GLS into a lower risk group despite transient relative GLS decrements ≥10%.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnthracyclinesCardiotoxicityEchocardiographyBreast NeoplasmsStroke VolumeVentricular Function, LeftHumansFemaleMiddle AgedProspective StudiesVentricular Dysfunction, LeftFollow-Up StudiesHeart Ventricles

Stichwörter der Autor:innen

Anthtracycline chemotherapyBreast cancerGlobal longitudinal systolic strainTransthoracic echocardiography

Substanzen

Anthracyclines

Autor:innen und Institutionen

  • Westmead Clinical School, The University of Sydney, Camperdown, Australia.
  • Department of Cardiology, Westmead Hospital, Sydney, Australia.
  • Westmead Applied Research Centre, The University of Sydney, Sydney, Australia.
  • Westmead Private Cardiology, Westmead, Australia.
  • Research and Education Network, Western Sydney Local Health District, Westmead Hospital, Sydney, Australia.
  • NHMRC Clinical Trials Centre, University of Sydney. Sydney, Sydney, Australia.

ORCID-Profile: Andrew Terluk

Zitieren

APA

Terluk, A., Stefani, L., Boyd, A., Vo, K., Byth, K., Hui, R., Richards, D., & Thomas, L. (2024). Redefining Anthracycline-Related Subclinical Cardiotoxicity: ‘Absolute’ and ‘Relative’ Change in Longitudinal Strain. ESC Heart Failure. https://doi.org/10.1002/ehf2.14884

Vancouver

Terluk A, Stefani L, Boyd A, Vo K, Byth K, Hui R, et al. Redefining Anthracycline-Related Subclinical Cardiotoxicity: ‘Absolute’ and ‘Relative’ Change in Longitudinal Strain. ESC Heart Failure. 2024. doi:10.1002/ehf2.14884

BibTeX
@article{Terluk2024,
  author = {Terluk, Andrew and Stefani, Luke and Boyd, Anita and Vo, Kim and Byth, Karen and Hui, Rina and Richards, David and Thomas, Liza},
  title = {Redefining Anthracycline-Related Subclinical Cardiotoxicity: ‘Absolute’ and ‘Relative’ Change in Longitudinal Strain},
  journal = {ESC Heart Failure},
  year = {2024},
  doi = {10.1002/ehf2.14884}
}
Kostenlos starten →